+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurostimulation Devices Market Size, Share & Trends Analysis Report By Application (Pain Management, Urinary & Fecal Incontinence, Epilepsy), By Product (Spinal Cord, Deep Brain Stimulators), And Segment Forecasts, 2019 - 2026

  • ID: 3934190
  • Report
  • Region: Global
  • 129 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • CODMAN & SHURTLEFF’S
  • CYBERONICS
  • INTRAPACE
  • MEDTRONIC
  • NEURONETICS, INC.
  • NEVRO CORPORATION
  • MORE
The global neurostimulation devices market size is expected to reach USD 12.6 billion by 2026 registering a CAGR of 12.5%, according to this report. Increasing prevalence of chronic diseases, such as migraine and epilepsy, due to unhealthy diet and lifestyle and rising geriatric population is expected to be the major growth-driving factor for the neurostimulation devices market. However, adverse effects and risks associated with neurostimulation devices and stringent regulations regarding product approval are expected to hamper the growth.

Increasing incidence of Road Traffic Accidents (RTAs) is another factor driving the product demand. Moreover, manufacturers are investing in R&D to develop new products with advance technology, such as MRI safety incorporated devices by Medtronic Inc. and minimally invasive transdermal neuromodulation technology by Neurowave Medical Technologies.

Asia Pacific is projected to be the fastest-growing regional market on account of rising healthcare expenditures and rapid economic growth in emerging countries, such as India and China. Presence of unmet medical needs and untapped markets are also boosting the market growth in the region. Moreover, changing lifestyle and eating habits resulting in various lifestyle-related diseases will contribute to the growth. Increasing RTAs and resultant nerve injuries, which require neurostimulation postoperatively, are also likely to boost product demand.

Further key findings from the study suggest:
  • North America is estimated to lead the neurostimulation devices market over the forecast period due to rising product demand as an add-on therapy and high disposable incomes and patient awareness levels
  • Presence of sophisticated healthcare infrastructure and growing prevalence of target diseases, such as epilepsy, Parkinson’s disease, and incontinence, are expected to drive the market further
  • Spinal cord stimulation products led the market in 2018 as they were the prime neurostimulation products to be commercialized. The segment further is estimated to maintain the dominance throughout the forecast period
  • Pain management was the dominant application segment, in terms of revenue share, in 2018 due to high prevalence of chronic pain disorders and extensive product usage for pain management
  • Some of the key companies are Medtronic PLC, St. Jude Medical, Boston Scientific Corp., Cyberonics, Inc., and Nevro Corp.
  • New product and technological development is the key business strategy followed by most if these companies

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • CODMAN & SHURTLEFF’S
  • CYBERONICS
  • INTRAPACE
  • MEDTRONIC
  • NEURONETICS, INC.
  • NEVRO CORPORATION
  • MORE
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.4 Purchased database
1.5 Internal database
1.6 Secondary sources & third party perspectives
1.7 Primary research
1.8 Information analysis
1.9 Data analysis models
1.10 Market formulation & data visualization
1.11 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Neurostimulation Devices Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Value Chain Analysis
3.4.1 Cost Structure Analysis
3.4.2 User Perspective Analysis
3.4.2.1 Consumer behavior analysis
3.4.2.2 Market influencer analysis
3.4.3 Cost Analysis Breakdown
3.4.4 List Of Key End Users, By Region
3.5 Technology Overview
3.5.1 TECHNOLOGY TIMELINE
3.6 Regulatory Framework
3.6.1 Reimbursement Framework
3.6.2 Standards And Compliances
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Growing geriatric population base
3.7.1.2 Introduction of technological advancements
3.7.1.3 Growing demand for neurostimulation devices as an add on therapy
3.7.1.4 Increasing global prevalence of chronic diseases
3.7.1.5 Growing prevalence of lifestyle induced disorders
3.7.1.6 External funding for executing research and development exercises
3.7.1.7 Growing demand for minimally invasive surgeries
3.7.2 Market Restraint Analysis
3.7.2.1 Adverse effects and risks associated with neurostimulation devices
3.7.2.2 Presence of stringent device approval regulations
3.7.2.3 Availability of external substitutes or alternative therapeutic procedures
3.7.3 Industry Challenges
3.7.3.1 Presence of ambiguous regulatory framework
3.8 Neurostimulation Devices Market Analysis Tools
3.8.1 Industry Analysis - PORTER’S
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrants
3.8.1.5 Competitive Rivalry
3.8.2 PESTEL ANALYSIS
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals And Strategic Alliances Analysis
3.8.3.1 Joint ventures
3.8.3.2 Mergers and acquisitions
3.8.3.3 Licensing and partnership
3.8.3.4 Technology collaborations
3.8.3.5 Strategic Divestments
3.8.4 Market Entry Strategies
3.8.5 Case Studies

Chapter 4 Neurostimulation Devices Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2018
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Share, By Region
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.4.3.2 Synergy Analysis: Major Deals And Strategic Alliances
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.5.2 Regional Network Map
4.5.3 Company Market Position Analysis
4.5.4 Supplier Ranking

Chapter 5 Neurostimulation Devices Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Neurostimulation Devices Market, By Product, 2015 To 2026
5.5 Market Size & Forecasts And Trend Analyses, 2015 To 2026
5.5.1 Spinal Cord Stimulator
5.5.1.1 Spinal Cord Stimulators Market, 2015 To 2026 (USD Million)
5.5.1.2 Spinal Cord Stimulators Market, 2015 To 2026 (‘000 Units)
5.5.1.3 Spinal Cord Stimulator Market, By Application, 2015 To 2026 (USD Million)
5.5.2 Deep Brain Stimulator
5.5.2.1 Deep Brain Stimulators Market, 2015 To 2026 Usd Million)
5.5.2.2 Deep Brain Stimulators Market, 2015 To 2026 (‘000 Units)
5.5.2.3 Deep Brain Stimulators Market, By Application, 2015 To 2026 (USD Million)
5.5.3 Sacral Nerve Stimulators Market
5.5.3.1 Sacral Nerve Stimulators Market, 2015 To 2026 (USD Million)
5.5.3.2 Sacral Nerve Stimulators Market, 2015 To 2026 (‘000 Units)
5.5.3.3 Sacral Nerve Stimulators Market, By Application, 2015 To 2026 (USD Million)
5.5.4 Vagus Nerve Stimulators Market
5.5.4.1 Vagus Nerve Stimulators Market, 2015 To 2026 (USD Million)
5.5.4.2 Vagus Nerve Stimulators Market, 2015 To 2026 (‘000 Units)
5.5.4.3 Vagus Nerve Stimulators, By Application, 2015 To 2026 (USD Million)
5.5.5 Gastric Electric stimulators Market
5.5.5.1 Gastric Electric Stimulators Market, 2015 To 2026 (USD Million)
5.5.5.2 Gastric Electric Stimulators Market, 2015 To 2026 (‘000 Units)
5.5.5.3 Gastric Electric Stimulators, By Application, 2015 To 2026 (USD Million)

Chapter 6 Neurostimulation Devices Market: Application Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Application Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Neurostimulation Devices Market, By Application, 2015 To 2026
6.5 Market Size & Forecasts And Trend Analyses, 2015 To 2026
6.5.1 Neurostimulation Devices For Pain Management Market
6.5.1.1 Neurostimulation Devices For Pain Management Market, 2015 To 2026 (USD Million)
6.5.2 Neurostimulation Devices For Epilepsy Market
6.5.2.1 Neurostimulation Devices For Epilepsy Market, 2015 To 2026 (USD Million)
6.5.3 Neurostimulation Devices For Essential Tremor Market
6.5.3.1 Neurostimulation Devices For Essential Tremor Market, 2015 To 2026 (USD Million)
6.5.4 Neurostimulation Devices For Urinary And Fecal Incontinence Market
6.5.4.1 Neurostimulation Devices For Urinary And Fecal Incontinence Market, 2015 To 2026 (USD Million)
6.5.5 Neurostimulation Devices For Depression Market
6.5.5.1 Neurostimulation Devices For Depression Market, 2015 To 2026 (USD Million)
6.5.6 Neurostimulation Devices For Dystonia Market
6.5.6.1 Neurostimulation Devices For Dystonia Market, 2015 To 2026 (USD Million)
6.5.7 Neurostimulation Devices For Gastroparesis Market
6.5.7.1 Neurostimulation Devices For Gastroparesis Market, 2015 To 2026 (USD Million)
6.5.8 Neurostimulation Devices For Parkinson's Disease Market
6.5.8.1 Neurostimulation Devices For Parkinson's Disease Market, 2015 To 2026 (USD Million)
6.5.9 Neurostimulation Devices For Other Diseases Market
6.5.9.1 Neurostimulation Devices For Other Diseases Market, 2015 To 2026 (USD Million)

Chapter 7 Neurostimulation Devices Market: Regional Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Regional Market Share and Leading Players, 2018
7.2.1 North America
7.2.2 Europe
7.2.3 Latin America
7.2.4 Asia Pacific
7.2.5 Middle East & Africa
7.3 Market Share Analysis By Country, 2018
7.3.1 North America
7.3.1.1 U.S.
7.3.1.2 Canada
7.3.2 Europe.
7.3.2.1 U.K.
7.3.2.2 Germany
7.3.2.3 Spain
7.3.2.4 France
7.3.2.5 Italy
7.3.2.6 Russia
7.3.3 Latin America
7.3.3.1 Brazil
7.3.3.2 Mexico
7.3.3.3 Argentina
7.3.4 Asia Pacific
7.3.4.1 Japan
7.3.4.2 China
7.3.4.3 India
7.3.4.4 South Korea
7.3.4.5 Singapore
7.3.4.6 Australia
7.3.5 Middle East & Africa
7.3.5.1 South Africa
7.3.5.2 Saudi Arabia
7.3.5.3 UAE
7.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
7.4.1 North America
7.4.2 Europe
7.4.3 Latin America
7.4.4 Asia Pacific
7.4.5 Middle East & Africa
7.5 Market Size & Forecasts, And Trend Analysis, 2018 To 2026
7.5.1 North America
7.5.1.1 North America Market Size, & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.1.3 Canada
7.5.1.3.1 Canada Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.2 Europe
7.5.2.1 Europe Market Size, & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.2.2 U.K.
7.5.2.2.1 U.K. Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.2.3 Germany
7.5.2.3.1 Germany Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.2.4 Spain
7.5.2.4.1 Spain Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.2.5 France
7.5.2.5.1 France Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.2.6 Italy
7.5.2.6.1 Italy Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.2.7 Russia
7.5.2.7.1 Russia Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.3 Latin America
7.5.3.1 Latin America Market Size, & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.3.2 Brazil
7.5.3.2.1 Brazil Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.3.3 Mexico
7.5.3.3.1 Mexico Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.3.4 Argentina
7.5.3.4.1 Argentina Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.4 Asia Pacific
7.5.4.1 Asia Pacific Market Size, & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.4.2 Japan
7.5.4.2.1 Japan Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.4.3 China
7.5.4.3.1 China Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.4.4 India
7.5.4.4.1 India Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.4.5 South Korea
7.5.4.5.1 South Korea Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.4.6 Singapore
7.5.4.6.1 Singapore Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.4.7 Australia
7.5.4.7.1 Australia Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.5 Middle East & Africa
7.5.5.1 Middle East & Africa Market Size, & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.5.3 Saudi Arabia
7.5.5.3.1 Saudi Arabia Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
7.5.5.4 Uae
7.5.5.4.1 Uae Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)

Chapter 8 COMPANY PROFILE
8.1 Company Profiles
8.1.1 MEDTRONIC
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 ST. JUDE MEDICAL
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 BOSTON SCIENTIFIC CORPORATION
8.1.3.1 Company overview
8.1.3.2 Financial Performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 CYBERONICS
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 NEVRO CORPORATION
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 NEURONETICS, INC.
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 UROPLASTY
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 CODMAN & SHURTLEFF’S
8.1.8.1 Company overview
8.1.8.2 Financial Performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 INTRAPACE
8.1.9.1 Company overview
8.1.9.2 Financial Performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • MEDTRONIC
  • ST. JUDE MEDICAL
  • BOSTON SCIENTIFIC CORPORATION
  • CYBERONICS
  • NEVRO CORPORATION
  • NEURONETICS, INC.
  • UROPLASTY
  • CODMAN & SHURTLEFF’S
  • INTRAPACE
Note: Product cover images may vary from those shown
Adroll
adroll